miRNA microarray reveals specific expression in the peripheral blood of glioblastoma patients

International Journal of Oncology

Volumn 45, Issue 2, 2014, Pages 746-756

  Dong, Lun ^a   Li, Yuping ^a   Han, Chongxu ^a   Wang, Xiaodong ^a   She, Lei ^a   Zhang, Hengzhu ^a  

^a CLINICAL MEDICAL COLLEGE OF YANGZHOU UNIVERSITY   (China)

Author keywords

Blood; Glioma; Microarray; MicroRNA; Pathway

Indexed keywords

MICRORNA; MICRORNA 320; MICRORNA 340; MICRORNA 576; MICRORNA 626; MICRORNA 7; TUMOR MARKER; UNCLASSIFIED DRUG; DNA;

ARTICLE; BIOINFORMATICS; BLOOD ANALYSIS; BLOOD LEVEL; CANCER PATIENT; CONTROLLED STUDY; DOWN REGULATION; EXTRACELLULAR SPACE; GENE EXPRESSION; GENE ONTOLOGY; GENE OVEREXPRESSION; GENE TARGETING; GLIOBLASTOMA; HUMAN; MICROARRAY ANALYSIS; PRIORITY JOURNAL; SENSITIVITY AND SPECIFICITY; SIGNAL TRANSDUCTION; UPREGULATION; BLOOD; BRAIN TUMOR; CLUSTER ANALYSIS; GENE REGULATORY NETWORK; GENETICS; REAL TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

BRAIN NEOPLASMS; CLUSTER ANALYSIS; DNA, NEOPLASM; GENE REGULATORY NETWORKS; GLIOBLASTOMA; HUMANS; MICROARRAY ANALYSIS; MICRORNAS; REAL-TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION;

EID: 84902584028     PISSN: 10196439     EISSN: 17912423     Source Type: Journal    
DOI: 10.3892/ijo.2014.2459     Document Type: Article

References (38)

1. Tzadok S, Beery E, Israeli M, et al: In vitro novel combinations of psychotropics and anti-cancer modalities in U87 human glioblastoma cells. Int J Oncol 37: 1043-1051, 2010.
2. Han L, Zhang K, Shi Z, et al: LncRNA profile of glioblastoma reveals the potential role of lncRNAs in contributing to glioblastoma pathogenesis. Int J Oncol 40: 2004-2012, 2012.
3. Wang Y, Chen L, Bao Z, et al: Inhibition of STAT3 reverses alkylator resistance through modulation of the AKT and β-catenin signaling pathways. Oncol Rep 5: 1173-1180, 2011.
4. Wang LF, Fokas E, Bieker M, et al: An HX Increased expression of EphA2 correlates with adverse outcome in primary and recurrent glioblastoma multiforme patients. Oncol Rep 19: 151-156, 2008. (Pubitemid 351176143)
5. Bartel DP: MicroRNAs: genomics, biogenesis, mechanism, and function. Cell 23: 281-297, 2004.
6. Ambros V: The functions of animal microRNAs. Nature 16: 350-355, 2004.
7. Grimson A, Farh KK, Johnston WK, et al: MicroRNA targeting specificity in mammals: determinants beyond seed pairing. Mol Cell 27: 91-105, 2007. (Pubitemid 46991392)
8. He L and Hannon GJ: MicroRNAs: small RNAs with a big role in gene regulation. Nat Rev Genet 5: 522-231, 2004.
9. Kim VN: MicroRNA biogenesis: coordinated cropping and dicing. Nat Rev Mol Cell Biol 6: 376-385, 2005.
10. Zhao C, Tian F, Yu Y, et al: miRNA-dysregulation associated with tenderness variation induced by acute stress in Angus cattle. J Anim Sci Biotechnol 3: 12-17, 2012.
11. Cuellar TL and McManus MT: MicroRNAs and endocrine biology. J Endocrinol 187: 327-332, 2005. (Pubitemid 43020253)
12. Poy MN, Eliasson L, Krutzfeldt J, et al: A pancreatic islet-specific microRNA regulates insulin secretion. Nature 432: 226-230, 2004. (Pubitemid 39545853)
13. Cheng H, Zhang L, Cogdell DE, et al: Circulating plasma MiR-141 is a novel biomarker for metastatic colon cancer and predicts poor prognosis. PLoS One 6: e17745, 2011.
14. Ng EK, Chong WW, Jin H, et al: Differential expression of microRNAs in plasma of patients with colorectal cancer: a potential marker for colorectal cancer screening. Gut 58: 1375-1381, 2009.
15. Rabinowits G, Gercel-Taylor C, Day JM, et al: Exosomal microRNA: a diagnostic marker for lung cancer. Clin Lung Cancer 1: 42-46, 2009.
16. Resnick KE, Alder H, Hagan JP, et al: The detection of differentially expressed microRNAs from the serum of ovarian cancer patients using a novel real-time PCR platform. Gynecol Oncol 112: 55-59, 2009.
17. Taylor DD and Gercel-Taylor C: MicroRNA signatures of tumor-derived exosomes as diagnostic biomarkers of ovarian cancer. Gynecol Oncol 110: 13-21, 2008. (Pubitemid 351853251)
18. Yaman Agaoglu F, Kovancilar M, Dizdar Y, et al: Investigation of miR-21, miR-141, and miR-221 in blood circulation of patients with prostate cancer. Tumour Biol 32: 583-588, 2011.
19. Li W1, Yuan Y, Huang L, et al: Metformin alters the expression profiles of microRNAs in human pancreatic cancer cells. Diabetes Res Clin Pract 96: 187-195, 2012.
20. Roth P, Wischhusen J, Happold C, et al: A specific miRNA signature in the peripheral blood of glioblastoma patients. J Neurochem 118: 449-457, 2011.
21. Kapranov P, Cheng J, Dike S, et al: RNA map reveals new RNA classes and a possible function for persvasive transcription. Science 316: 1484-1488, 2007. (Pubitemid 46906616)
22. Taft RJ, Pang KC, Mercer TR, et al: Non-coding RNAs: regulators of disease. Pathology 220: 126-139, 2010.
23. Zhang W, Edwards A, Fan W, et al: miRNA-mRNA correlation-network modules in human prostate cancer and the differences between primary and metastatic tumor subtypes. PLoS One 7: e40130, 2012.
24. Williams AE: Functional aspects of animal microRNAs. Cell Mol Life Sci 65: 545-562, 2008.
25. Place RF, Li LC, Pookot D, et al: MicroRNA-373 induces expression of genes with complementary promoter sequences. Proc Natl Acad Sci USA 105: 1608-1613, 2008. (Pubitemid 351346562)
26. Brennecke J, Hipfner DR, Stark A, et al: Bantam encodes a develop mentally regulated microRNA that controls cell proliferation and regulates the proapoptotic gene hid in Drosophila. Cell 113: 25-36, 2003. (Pubitemid 36411957)
27. Chen X, Ba Y, Ma L, et al: Characterization of microRNAs in serum: a novel class of biomarkers for diagnosis of cancer and other diseases. Cell Res 18: 997-1006, 2008.
28. Kosaka N, Iguchi H and Ochiya T: Circulating microRNA in body fluid: a new potential biomarker for cancer diagnosis and prognosis. Cancer Sci 101: 2087-2092, 2010.
29. Li Z, Gu X, Fang Y, et al: microRNA expression profiles in human colorectal cancers with brain metastases. Oncol Lett 3: 346-350, 2012.
30. Díaz-Prado S, Cicione C, Muiños-López E, et al: Characterization of microRNA expression profiles in normal and osteoarthritic human chondrocytes. BMC Musculoskelet Disord 13: 144, 2012.
31. Giles KM, Brown RA, Epis MR, et al: miRNA-7-5p inhibits melanoma cell migration and invasion. Biochem Biophys Res Commun 430: 706-710, 2013.
32. Dong L, Han C, Zhang H, et al: Construction of a recombinant lentivirus containing human microRNA-7-3 and its inhibitory effects on glioma proliferation. Neural Regener Res 7: 2144-2150, 2012.
33. Bader AG, Brown D and Winkler M: The promise of microRNA replacement therapy. Cancer Res 70: 7027-7030, 2010.
34. Giles KM, Brown RA, Epis MR, et al: miRNA-7-5p inhibits melanoma cell migration and invasion. Biochem Biophys Res Commun 430: 706-710, 2013.
35. McDonald JS, Milosevic D, Reddi HV, et al: Analysis of circulating microRNA: preanalytical and analytical challenges. Clin Chem 57: 833-840, 2011.
36. Jorde R, Svartberg J, Joakimsen RM and Coucheron DH: Plasma profile of microRNA after supplementation with high doses of vitamin D3 for 12 months. BMC Res Notes 5: 245, 2012.
37. Chen Y, Gelfond JA, McManus LM and Shireman PK: Reproducibility of quantitative RT-PCR array in miRNA expression profiling and comparison with microarray analysis. BMC Genomics 10: 407, 2009.
38. Jensen SG, Lamy P, Rasmussen MH, et al: Evaluation of two commercial global miRNA expression profiling platforms for detection of less abundant miRNAs. BMC Genomics 12: 435, 2011.